Orchestra BioMed Holdings Inc

OBIONASDAQ · USD
6.22USD+0.14 (+2.31%)
1310

Orchestra BioMed Holdings Inc (OBIO) Option Chain

As of September 29, 2026, Orchestra BioMed Holdings Inc is trading at $6.22, a +2.31% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 77.5%. IV Rank is 9%.

Read more

Tracking the OBIO option chain helps you see every strike and expiry on Orchestra BioMed Holdings Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Orchestra BioMed Holdings Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of OBIO options activity at a glance. Use our scanner to monitor the OBIO option chain in real time and filter for the OBIO options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For OBIO stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the OBIO option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where OBIO stock options are being actively traded and where they are not.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease.

Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Orchestra BioMed Holdings Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen OBIO options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of OBIO stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile6.75% Subdued
  • Market cap (M$)365
  • 52 weeks high-6.17%
  • 52 weeks low153.33%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$12.14
    92.93% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-09
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.00
  • EPS growth next 5 years4.97%

As of September 29, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.0000-0.273.722.904.002.50-58.88—0.750.000.7500100.00
13.3230-0.121.220.551.655.00-17.76—0.750.000.750186.68
91.0042200.200.00—0.207.50+23.360.952.101.280.24019.00
99.90000.750.00—0.7510.00+64.473.404.603.780.22100.10

As of September 29, 2026

Scan the full option chain in one place

Browse the full OBIO option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial